Bubs Australia FCF Margin
The Free Cash Flow Margin of Bubs Australia (BUB.AX) as of Jul 27, 2026 is 5.90 %. In the previous year, Free Cash Flow Margin was -33.25 % — a change of -117.74% (higher).
Get this data via API
Financial Data API
FCF Margin
5.90 %
YoY
-117.74%
Last updated:
Free Cash Flow Margin of Bubs Australia is 2026 5.90 % . Free Cash Flow Margin of Bubs Australia was 2025 -33.25 % . It decreases by -117.74% higher compared to the previous year.
Access this data via the Eulerpool API
Bubs Australia Stock analysis
What does Bubs Australia do? Bubs Australia Ltd is an Australian company specializing in the production and distribution of infant and children's nutrition. The company originated from a small family business that produced goat's milk and later invested in macadamia nut plantations before expanding into the baby food segment.
In the following years, Bubs Australia gradually expanded its range and invested in expanding production capacity. Today, the company offers a wide range of products and categories, including baby formula, puree blends, snacks, and beverages. The company distributes both goat's and cow's milk products and operates successfully in Australia, Asia, the superfood market, and the US market since 2019.
Bubs Australia's business model is based on strong in-house production and the marketing of regional products. The company purchases milk products from cooperating farmers and processors, processes them in their own factories, and then implements a global distribution strategy. The company sees China as one of the most important foreign markets, where it collaborates with local partners and successfully markets its products.
The company's product categories range from baby formula, infant nutrition, and puree blends to snacks like cereal bars and fruit purees. Bubs Australia places emphasis on using natural and sustainable ingredients without artificial additives. The focus is on products with a high content of minerals and nutrients important for children's growth and development.
In particular, Bubs Australia's baby formula is often highly rated in professional circles due to its natural ingredients and absence of artificial additives. Experts believe that the company's goat's milk has better digestibility and higher nutrient content compared to cow's milk-based formulas.
Overall, Bubs Australia has captured the Asian market where it has steadily increased its sales and revenue in recent years, becoming the market leader in goat's milk-based baby formula. However, the company's dynamic growth strategy is subject to controversy. Some experts criticize Bubs Australia for being too dependent on the Asian market and taking on a high level of economic risk. The focus on China also presents additional uncertainties.
Bubs Australia is considered a pioneer in the production of natural infant nutrition, particularly using goat's milk, and continues to grow dynamically. Currently, the company is trying to diversify its global activities and intensify its presence in the US market to solidify its position as a leading provider of baby food. Bubs Australia is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Bubs Australia stock
Free Cash Flow Margin of Bubs Australia is 5.90 % in 2026.
Access this data via the Eulerpool API
Margins — Bubs Australia
All Key Metrics — Bubs Australia
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth